This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Fred Hutchinson Cancer Center. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Eric Blackstone: Innovator in Cellular Survivability
Introduction
Eric Blackstone is a notable inventor based in Seattle, WA. He has made significant contributions to the field of cellular survivability through his innovative research and patents. His work focuses on enhancing the survivability of cells, tissues, and organs, which has important implications for medical science and organ transplantation.
Latest Patents
Eric Blackstone holds a patent for "Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms." This invention involves the use of oxygen antagonists and other active compounds to induce stasis or pre-stasis in biological materials. The patent outlines various compositions, methods, and apparatuses designed to preserve and protect cells, tissues, and organs. Specific applications of this invention include therapeutic methods for organ transplantation, wound healing, and treatment of conditions such as neurodegeneration and cancer.
Career Highlights
Eric Blackstone is affiliated with the Fred Hutchinson Cancer Center, where he continues to advance his research in cellular survivability. His work is critical in developing new therapeutic approaches that can significantly improve patient outcomes in various medical scenarios.
Collaborations
Throughout his career, Eric has collaborated with esteemed colleagues, including Mike Morrison and Dana K. Miller. These collaborations have further enriched his research and contributed to the advancement of medical science.
Conclusion
Eric Blackstone is a pioneering inventor whose work in enhancing cellular survivability has the potential to transform medical practices. His innovative approaches and dedication to research continue to make a significant impact in the field.